Federal health regulators are weighing restrictions on Robitussin, NyQuil and other cough suppressants to curb cases of abuse that send thousands of people to the hospital each year. More Details
Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a long federal investigation into its marketing of the top-selling, botulin-based drug. More Details
No comments:
Post a Comment